Loading the security overview…
Where the tokens are
| Quarter | Reported | EPS | EPS vs year ago | Revenue | Revenue vs year ago | Consensus EPS |
|---|---|---|---|---|---|---|
| Q4 FY26ended Jun 30, 2026 | Aug 3, 2026 | $1.34 | −50.0% | $1.95B | −2.0% | $1.64 |
| Q3 FY26ended Mar 31, 2026 | May 4, 2026 | $1.54 | +2.7% | $1.67B | +0.1% | $1.57 |
| Q2 FY26ended Dec 31, 2025 | — | $1.29 | −16.2% | $1.67B | −0.8% | — |
| Q1 FY26ended Sep 30, 2025 | — | $0.65 | −18.8% | $1.43B | −18.9% | — |
| Q4 FY25ended Jun 30, 2025 | — | $2.68 | +55.8% | $1.99B | +4.5% | — |
| Q3 FY25ended Mar 31, 2025 | — | $1.50 | — | $1.67B | −8.0% | — |
| Q2 FY25ended Dec 31, 2024 | — | $1.54 | +105.3% | $1.69B | −15.3% | — |
| Q1 FY25ended Sep 30, 2024 | — | $0.80 | +370.6% | $1.76B | +27.1% |
Growth compares each quarter with the same fiscal quarter a year earlier, and is left blank where that quarter is missing or its figure was zero or a loss. Consensus is the estimate published before each report. It usually refers to adjusted EPS, so it is shown beside the GAAP figure rather than subtracted from it: the difference would not be a beat or a miss.
Figures describe Clorox shares, not any token. As of Aug 3, 2026, from Massive's standardised financials and the earnings calendar.
| — |
| Q4 FY24ended Jun 30, 2024 | — | $1.72 | — | $1.90B | — | — |
| Q3 FY24ended Mar 31, 2024 | — | −$0.41 | — | $1.81B | — | — |
| Q2 FY24ended Dec 31, 2023 | — | $0.75 | — | $1.99B | — | — |
| Q1 FY24ended Sep 30, 2023 | — | $0.17 | — | $1.39B | — | — |